Form 4: Hims & Hers CCO Michael Chi Executes Options, Vests RSUs

Hims & Hers Chief Commercial Officer Michael Chi executed stock options and vested restricted stock units, leading to both acquisitions and sales of Class A Common Stock on September 15, 2025, under a Rule 10b5-1 plan.

Summary

• Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc. (HIMS), engaged in multiple transactions involving the company's Class A Common Stock on September 15, 2025.
• Transactions included the exercise of stock options to acquire a total of 4,150 shares at prices ranging from $5.01 to $11.53 per share.
• Concurrently, 4,150 shares were disposed of at a price of $56.00 per share, likely as part of a cashless exercise or related sale.
• A total of 72,106 Restricted Stock Units (RSUs) vested, resulting in the acquisition of an equal number of Class A Common Stock shares.
• To cover tax withholding obligations related to the RSU vesting, 39,872 shares were disposed of at a price of $53.96 per share.
• All reported stock option exercises and sales were conducted pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025.
• Following these transactions, Michael Chi's direct beneficial ownership of Class A Common Stock increased to 310,888 shares.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive. While there are sales, they are part of a pre-arranged 10b5-1 plan and primarily for tax purposes or cashless exercises. The executive also increased their net beneficial ownership, indicating continued alignment with shareholder interests and realization of compensation value.

Positives

• The Chief Commercial Officer exercised stock options at significantly lower prices ($5.01 to $11.53) and sold shares at a much higher price ($56.00), indicating a profitable realization of compensation.
• A substantial number of Restricted Stock Units (72,106 shares) vested, demonstrating the executive's continued long-term compensation alignment with company performance.
• Despite sales for tax and other purposes, the executive's net direct beneficial ownership of Class A Common Stock increased by 32,234 shares, reflecting continued stake in the company.

Negatives

• The disposition of 4,150 shares at $56.00 and 39,872 shares at $53.96 reduces the executive's direct ownership, although a net increase in shares beneficially owned was observed.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on insider ownership changes.

Industry Context

This insider transaction report is a routine disclosure for publicly traded companies and does not provide specific insights into broader industry trends or competitive positioning beyond the executive's compensation structure within Hims & Hers Health, Inc.

Stakeholder Impact

• Shareholders: The transactions are routine insider compensation events under a pre-arranged plan and are unlikely to have a significant direct impact on the company's operational or strategic direction. The net increase in shares held by the CCO may be viewed positively as continued insider alignment.
• Employees: These transactions reflect standard executive compensation practices, which may be part of broader employee incentive programs.

Next Steps

• Continued vesting of remaining stock options and Restricted Stock Units according to their respective service-based vesting schedules.

Key Dates

Recommendation

The filing details routine insider transactions (option exercises, RSU vesting, and associated sales for tax/cashless exercise) executed under a pre-established Rule 10b5-1 trading plan. Such transactions are generally expected and do not typically signal a change in the company's fundamental outlook or warrant a shift in investment recommendation. The net increase in the executive's beneficial ownership is a neutral to slightly positive indicator, but not enough to change a 'hold' stance based solely on this filing.

Keywords

Hims & Hers Health, HIMS, Michael Chi, Chief Commercial Officer, Form 4, Insider Transaction, Stock Options, Restricted Stock Units, RSU Vesting, Rule 10b5-1 Plan, Beneficial Ownership